A Single Lipid Nanoparticle Formulation Enables Delivery of Diverse RNA Therapeutics to Human Muscle Models of Duchenne Muscular Dystrophy
Paola Galbiati, Delphine Leclerc, Margaux Mombled…·Mario Amendola
Author
InsermORCID 0000-0003-2704-7303Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Paola Galbiati, Delphine Leclerc, Margaux Mombled…·Mario Amendola
Guillaume Corre, Marine Rouillon, Margaux Mombled, Amendola Mario
GENETHOFF is a Snakemake workflow for analyzing CRISPR/Cas9 off-targets from GUIDE-Seq data, handling multiple organisms and Cas nucleases through a metadata-driven approach.
Letizia Fontana, Pierre Martinucci, Simone Amistadi…·Annarita Miccio
This study uses multiplex base editing to target BCL11A enhancers, increasing fetal hemoglobin production and reducing sickle cell disease symptoms without causing significant genomic damage.
Anne Chalumeau, Maria Bou Dames, Letizia Fontana…·Mégane Brusson
This paper describes a prime editing strategy to modify γ-globin promoters in HSPCs to increase HbF expression for sickle cell disease treatment.
Giulia Hardouin, Pierre Martinucci, Samantha Scaramuzza…·Annarita Miccio
Preclinical safety and efficacy studies of a new gene therapy approach for patients with severe β-hemoglobinopathies.